Patents by Inventor Marjorie C. Green

Marjorie C. Green has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES COMPRISING GDC-9545 AND A CDK4/6 INHIBITOR
    Publication number: 20240173306
    Abstract: Provided herein are combination therapies comprising GDC-9545 and a CDK4/6 inhibitor for treating locally advanced breast cancer or metastatic breast cancer.
    Type: Application
    Filed: January 26, 2024
    Publication date: May 30, 2024
    Applicant: Genentech, Inc.
    Inventors: Jennifer O'Hara LAUCHLE, Sandra MILAN, Melanie Carol SMITT, Marjorie C. GREEN
  • Treatment of breast cancer using combination therapies comprising GDC-9545 and a CDK4/6 inhibitor
    Patent number: 11918561
    Abstract: Provided herein are combination therapies comprising GDC-9545 and a CDK4/6 inhibitor for treating locally advanced breast cancer or metastatic breast cancer.
    Type: Grant
    Filed: May 10, 2021
    Date of Patent: March 5, 2024
    Assignee: Genentech, Inc.
    Inventors: Jennifer O'Hara Lauchle, Sandra Milan, Melanie Carol Smitt, Marjorie C. Green
  • TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES COMPRISING GDC-9545 AND A CDK4/6 INHIBITOR
    Publication number: 20210353601
    Abstract: Provided herein are combination therapies comprising GDC-9545 and a CDK4/6 inhibitor for treating locally advanced breast cancer or metastatic breast cancer.
    Type: Application
    Filed: May 10, 2021
    Publication date: November 18, 2021
    Applicant: Genentech, Inc.
    Inventors: Jennifer O'Hara LAUCHLE, Sandra MILAN, Melanie Carol SMITT, Marjorie C. GREEN
  • METHODS OF TREATING EARLY BREAST CANCER WITH TRASTUZUMAB-MCC-DM1 AND PERTUZUMAB
    Publication number: 20170035907
    Abstract: Methods of treating patients having HER2-positive, operable, locally advanced or inflammatory breast cancer with the antibody-drug conjugate Trastuzumab-MCC-DM1 and Pertuzumab are provided.
    Type: Application
    Filed: October 21, 2016
    Publication date: February 9, 2017
    Inventors: Marjorie C. Green, Alice Elizabeth Guardino